AUTHOR=Dhiman Neetu Rani , Singh Surbhi , Singh Royana , Kumar Anand , Singh Varun Kumar , Pathak Abhishek , Chaurasia Rameshwar Nath , Mishra Vijay Nath , Srivastava Niraj Kumar , Sahu Swati , Pandey Nikhil , Joshi Deepika TITLE=Urinary based biomarkers identification and genetic profiling in Parkinson’s disease: a systematic review of metabolomic studies JOURNAL=Frontiers in Bioinformatics VOLUME=Volume 5 - 2025 YEAR=2025 URL=https://www.frontiersin.org/journals/bioinformatics/articles/10.3389/fbinf.2025.1513790 DOI=10.3389/fbinf.2025.1513790 ISSN=2673-7647 ABSTRACT=BackgroundParkinson’s disease is a complex, age-related, neurodegenerative disease associated with dopamine deficiency and both motor and nonmotor deficits. Therapeutic pathways remain challenging in Parkinson’s disease due to the low accuracy of early diagnosis, the difficulty in monitoring disease progression, and the limited availability of treatment options.ObjectivesFew data are present to identify urinary biomarkers for various ailments, potentially aiding in the diagnosis and tracking of illness progression in individuals with Parkinson’s disease. Thus, the analysis of urinary metabolomic biomarkers (UMB) for early and mid-stage idiopathic Parkinson’s disease (IPD) is the main goal of this systematic review.MethodsFor this study, six electronic databases were searched for articles published up to 23 February 2024: PubMed, Ovid Medline, Embase, Scopus, Science Direct, and Cochrane. 5,377 articles were found and 40 articles were screened as per the eligibility criteria. Out of these, 7 controlled studies were selected for this review. Genetic profiling for gene function and biomarker interactions between urinary biomarkers was conducted using the STRING and Cytoscape database.ResultsA total of 40 metabolites were identified to be related to the early and mid-stage of the disease pathology out of which three metabolites, acetyl phenylalanine (a subtype of phenylalanine), tyrosine and kynurenine were common and most significant in three studies. These metabolites cause impaired dopamine synthesis along with mitochondrial disturbances and brain energy metabolic disturbances which are considered responsible for neurodegenerative disorders. Furoglycine, Cortisol, Hydroxyphenylacetic acid, Glycine, Tiglyglycine, Aminobutyric acid, Hydroxyprogesterone, Phenylacetylglutamine, and Dihydrocortisol were also found commonly dysregulated in two of the total 7 studies. 158 genes were found which are responsible for the occurrence of PD and metabolic regulation of the corresponding biomarkers from our study.ConclusionThe current review identified acetyl phenylalanine (a subtype of phenylalanine), tyrosine and kynurenine as potential urinary metabolomic biomarkers for diagnosing PD and identifying disease progression.